E. C. Rodriguez-merchan, Preoperative Aspiration Culture (PAC) for the Diagnosis of Infection in a, Prosthetic Knee Joint. Arch. Bone Jt. Surg, vol.6, pp.342-345, 2018.

O. Spilf, Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis), Med. Mal. Infect, vol.40, pp.185-211, 2010.

D. R. Osmon, E. F. Berbari, A. R. Berendt, D. Lew, W. Zimmerli et al., Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America, Clin. Infect. Dis, vol.56, pp.1-25, 2013.

S. Esposito, S. Leone, M. Bassetti, S. Borrè, F. Leoncini et al., Bone Joint Infections Committee for the Italian Society of Infectious Tropical Diseases (SIMIT). Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults, Infection, vol.37, pp.478-496, 2009.

J. Ariza, J. Cobo, J. Baraia-etxaburu, N. Benito, G. Bori et al., Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Enferm. Infecc. Microbiol. Clin, vol.35, pp.189-195, 2017.

C. Joseph, O. Robineau, M. Titecat, S. Putman, N. Blondiaux et al., Daptomycin versus Vancomycin as Post-Operative Empirical Antibiotic Treatment for Prosthetic Joint Infections: A Case-Control Study, J. Bone Jt. Infect, vol.4, pp.72-75, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02573124

E. Takoudju, P. Bemer, S. Touchais, N. Asseray, S. Corvec et al., Nantes Bone and Joint Infections Study Group. Bacteriological relevance of linezolid versus vancomycin in postoperative empirical treatment of osteoarticular infections: A retrospective single-center study, Int. J. Antimicrob. Agents, vol.52, pp.663-666, 2018.

L. Deroche, C. Plouzeau, P. Bémer, D. Tandé, A. S. Valentin et al., Probabilistic chemotherapy in knee and hip replacement infection: The place of linezolid, Eur. J. Clin. Microbiol. Infect. Dis, vol.38, pp.1659-1663, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02627582

A. Aalirezaie, T. W. Bauer, H. Fayaz, W. Griffin, C. A. Higuera et al., Hip and Knee Section, Diagnosis, Reimplantation: Proceedings of International Consensus on Orthopedic Infections, J. Arthroplast, vol.34, pp.369-379, 2019.

W. C. Rutter and D. S. Burgess, Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin, Antimicrob. Agents Chemother, vol.62, 2018.

C. Triffault-fillit, F. Valour, R. Guillo, M. Tod, S. Goutelle et al., Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy, Antimicrob. Agents Chemother, vol.62, pp.163-181, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02076761

P. Bémer, C. Plouzeau, D. Tande, J. Léger, B. Giraudeau et al., Evaluation of 16S rRNA Gene PCR Sensitivity and Specificity for Diagnosis of Prosthetic Joint Infection: A Prospective Multicenter Cross-Sectional Study, J. Clin. Microbiol, vol.52, pp.3583-3589, 2014.

D. T. Tsukayama, R. Estrada, and R. B. Gustilo, Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections, J. Bone Jt. Surg. Am, vol.78, pp.512-523, 1996.

D. T. Tsukayama, V. M. Goldberg, and R. Kyle, Diagnosis and management of infection after total knee arthroplasty, J. Bone Jt. Surg. Am, vol.85, pp.75-80, 2003.

E. Senneville, D. Joulie, L. Legout, M. Valette, H. Dezèque et al., Outcome and Predictors of Treatment Failure in Total Hip/Knee Prosthetic Joint Infections Due to Staphylococcus aureus, Clin. Infect. Dis, vol.53, pp.334-340, 2011.

T. N. Peel, A. C. Cheng, P. F. Choong, and K. L. Buising, Early onset prosthetic hip and knee joint infection: Treatment and outcomes in Victoria, Australia. J. Hosp. Infect, vol.82, pp.248-253, 2012.

H. Rieber, A. Frontzek, J. Jerosch, M. Alefeld, T. Strohecker et al., Periprosthetic joint infection caused by anaerobes. Retrospective analysis reveals no need for prolonged cultivation time if sensitive supplemented growth media are used, Anaerobe, vol.50, pp.12-18, 2018.

N. Renz, S. Mudrovcic, C. Perka, and A. Trampuz, Orthopedic implant-associated infections caused by Cutibacterium spp.-A remaining diagnostic challenge, PLoS ONE, vol.13, 2018.

D. A. Bossard, B. Ledergerber, P. O. Zingg, C. Gerber, A. S. Zinkernagel et al., Optimal Length of Cultivation Time for Isolation of Propionibacterium acnes in Suspected Bone and Joint Infections Is More than 7 Days, J. Clin. Microbiol, vol.54, pp.3043-3049, 2016.

R. J. Holleyman, D. J. Deehan, A. Charlett, K. Gould, and P. N. Baker, Does pre-operative sampling predict intra-operative cultures and antibiotic sensitivities in knee replacements revised for infection? A study using the NJR dataset, Knee Surg. Sports Traumatol. Arthrosc, vol.24, pp.3056-3063, 2016.

S. Frangiamore, A. Saleh, M. Grosso, B. Alolabi, T. Bauer et al., Early Versus Late Culture Growth of Propionibacterium acnes in Revision Shoulder Arthroplasty, J. Bone Jt. Surg, vol.97, pp.1149-1158, 2015.

N. Benito, I. Mur, A. Ribera, A. Soriano, D. Rodríguez-pardo et al., The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms, J. Clin. Med, vol.8, p.673, 2019.

C. Triffault-fillit, T. Ferry, F. Laurent, P. Pradat, C. Dupieux et al., Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: A prospective cohort study, Clin. Microbiol. Infect, vol.25, pp.353-358, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01911512

A. Trampuz, K. E. Piper, M. J. Jacobson, A. D. Hanssen, K. K. Unni et al., Sonication of removed hip and knee prostheses for diagnosis of infection, N. Engl. J. Med, vol.357, pp.654-663, 2007.

T. N. Peel, B. L. Dylla, J. G. Hughes, D. T. Lynch, K. E. Greenwood-quaintance et al., Improved Diagnosis of Prosthetic Joint Infection by Culturing Periprosthetic Tissue Specimens in Blood Culture Bottles, vol.7, pp.1776-1791, 2016.

P. Bémer, J. Léger, S. Milin, C. Plouzeau, A. S. Valentin et al., Histopathological Diagnosis of Prosthetic Joint Infection: Does a Threshold of 23 Neutrophils Do Better than Classification of the Periprosthetic Membrane in a Prospective Multicenter Study?, J. Clin. Microbiol, vol.56, pp.536-554, 2018.

J. Parvizi, T. L. Tan, K. Goswami, C. Higuera, C. Della-valle et al., Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria, J. Arthroplast, vol.33, pp.1309-1314, 2018.

J. Parvizi, O. Erkocak, and C. D. Valle, Culture-Negative Periprosthetic Joint Infection, J. Bone Jt. Surg, vol.96, pp.430-436, 2014.

H. Rieber, A. Frontzek, and M. Fischer, Periprosthetic joint infection associated with Mycoplasma hominis after transurethral instrumentation in an immunocompetent patient. Unusual or underestimated? A case report and review of the literature, Int. J. Infect. Dis, vol.82, pp.86-88, 2019.

H. K. Li, I. Rombach, R. Zambellas, A. S. Walker, M. A. Mcnally et al., Oral versus Intravenous Antibiotics for Bone and Joint Infection, N. Engl. J. Med, vol.380, pp.425-436, 2019.

M. Marks, L. C. Bell, I. Jones, T. Rampling, K. Kranzer et al., Clinical and economic impact of implementing OVIVA criteria on patients with bone and joint infections in OPAT, Clin. Infect. Dis, 2019.

B. Navalkele, J. M. Pogue, S. Karino, B. Nishan, M. Salim et al., Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime, Clin. Infect. Dis, vol.64, pp.116-123, 2017.

M. K. Luther, T. T. Timbrook, A. R. Caffrey, D. Dosa, T. P. Lodise et al., Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis

, Crit. Care Med, vol.46, pp.12-20, 2018.

D. J. Schreier, K. B. Kashani, A. Sakhuja, K. C. Mara, M. S. Tootooni et al., Incidence of acute kidney injury among critically ill patients with brief empiric use of anti-pseudomonal beta-lactams with vancomycin, Clin. Infect. Dis, vol.68, pp.1456-1462, 2018.

C. Weßels, B. Strommenger, I. Klare, J. Bender, S. Messler et al., Emergence and control of linezolid-resistant Staphylococcus epidermidis in an ICU of a German hospital, J. Antimicrob. Chemother, vol.73, pp.1185-1193, 2018.

L. Dortet, P. Glaser, N. Kassis-chikhani, D. Girlich, P. Ichai et al., Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France, J. Antimicrob. Chemother, vol.73, pp.41-51, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-02565669

S. E. Beekmann, D. N. Gilbert, and P. M. Polgreen, Toxicity of extended courses of linezolid: Results of an Infectious Diseases Society of America Emerging Infections Network survey, Diagn. Microbiol. Infect. Dis, vol.62, pp.407-410, 2008.

L. M. Boak, C. R. Rayner, M. L. Grayson, D. L. Paterson, D. Spelman et al., Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid. Antimicrob. Agents Chemother, vol.58, pp.2334-2343, 2014.